Corrie S R, Coffey J W, Islam J, Markey K A, Kendall M A F
The University of Queensland, Australian Institute for Bioengineering and Nanotechnology, Delivery of Drugs and Genes Group (D2G2), St Lucia, Queensland 4072, Australia.
Analyst. 2015 Jul 7;140(13):4350-64. doi: 10.1039/c5an00464k.
Biosensors are being developed to provide rapid, quantitative, diagnostic information to clinicians in order to help guide patient treatment, without the need for centralised laboratory assays. The success of glucose monitoring is a key example of where technology innovation has met a clinical need at multiple levels – from the pathology laboratory all the way to the patient's home. However, few other biosensor devices are currently in routine use. Here we review the challenges and opportunities regarding the integration of biosensor techniques into body fluid sampling approaches, with emphasis on the point-of-care setting.
生物传感器正在被开发,以便为临床医生提供快速、定量的诊断信息,从而帮助指导患者治疗,而无需进行集中式实验室检测。血糖监测的成功是技术创新在多个层面满足临床需求的一个关键例子——从病理实验室一直到患者家中。然而,目前很少有其他生物传感器设备在常规使用。在此,我们回顾了将生物传感器技术整合到体液采样方法中所面临的挑战和机遇,重点是即时检测环境。